Keros Therapeutics, Inc. (KROS)
9.36
-0.09
(-0.95%)
USD |
NASDAQ |
Nov 06, 16:00
9.315
-0.04
(-0.48%)
After-Hours: 20:00
Keros Therapeutics Market Cap : 185.58M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 185.58M |
| November 05, 2026 | 187.37M |
| November 04, 2026 | 214.73M |
| November 03, 2026 | 214.73M |
| November 02, 2026 | 213.34M |
| October 30, 2026 | 218.89M |
| October 29, 2026 | 225.24M |
| October 28, 2026 | 230.19M |
| October 27, 2026 | 226.53M |
| October 26, 2026 | 224.64M |
| October 23, 2026 | 223.65M |
| October 22, 2026 | 225.04M |
| October 21, 2026 | 221.67M |
| October 20, 2026 | 226.03M |
| October 19, 2026 | 219.29M |
| October 16, 2026 | 211.36M |
| October 15, 2026 | 220.08M |
| October 14, 2026 | 219.09M |
| October 13, 2026 | 222.66M |
| October 12, 2026 | 230.19M |
| October 09, 2026 | 236.94M |
| October 08, 2026 | 230.79M |
| October 07, 2026 | 222.26M |
| October 06, 2026 | 218.30M |
| October 05, 2026 | 228.41M |
| Date | Value |
|---|---|
| October 02, 2026 | 225.24M |
| October 01, 2026 | 223.25M |
| September 30, 2026 | 226.03M |
| September 29, 2026 | 221.87M |
| September 28, 2026 | 223.65M |
| September 25, 2026 | 230.39M |
| September 24, 2026 | 229.00M |
| September 23, 2026 | 230.59M |
| September 22, 2026 | 232.57M |
| September 21, 2026 | 227.62M |
| September 18, 2026 | 221.87M |
| September 17, 2026 | 225.24M |
| September 16, 2026 | 212.94M |
| September 15, 2026 | 221.47M |
| September 14, 2026 | 222.26M |
| September 11, 2026 | 219.69M |
| September 10, 2026 | 221.47M |
| September 09, 2026 | 224.25M |
| September 08, 2026 | 221.47M |
| September 04, 2026 | 224.44M |
| September 03, 2026 | 220.28M |
| September 02, 2026 | 222.66M |
| September 01, 2026 | 219.49M |
| August 31, 2026 | 219.69M |
| August 28, 2026 | 218.69M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agios Pharmaceuticals, Inc. | 1.753B |
| Viking Therapeutics, Inc. | 3.423B |
| Protagonist Therapeutics, Inc. | 8.539B |
| ACADIA Pharmaceuticals, Inc. | 3.654B |
| Alnylam Pharmaceuticals, Inc. | 20.88B |
Market Cap Related Metrics
| PS Ratio | 16.72 |
| Price to Book Value | 0.7075 |
| Price | 9.36 |
| Earnings Yield | -39.53% |